Characterization of patients (pts) with long-term responses to rucaparib in recurrent ovarian cancer (OC).

Authors

Elizabeth Swisher

Elizabeth M. Swisher

University of Washington, Seattle, WA

Elizabeth M. Swisher , Rebecca Sophie Kristeleit , Amit M. Oza , Anna Tinker , Isabelle Laure Ray-Coquard , Ana Oaknin , Robert L. Coleman , Howard A. Burris III , Carol Aghajanian , David M. O'Malley , Alexandra Leary , Stephen Welch , Diane M. Provencher , Geoffrey Shapiro , Lee-may Chen , Ronnie Shapira-Frommer , Sandra Goble , Lara Maloney , Kevin K. Lin , Iain A. McNeish

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT01482715; NCT01891344

Citation

J Clin Oncol 38: 2020 (suppl; abstr 6015)

DOI

10.1200/JCO.2020.38.15_suppl.6015

Abstract #

6015

Poster Bd #

186

Abstract Disclosures